Published in Cancer Gene Ther on February 05, 2010
FGF15/19 regulates hepatic glucose metabolism by inhibiting the CREB-PGC-1α pathway. Cell Metab (2011) 1.97
Therapeutic improvement of a stroma-targeted CRAd by incorporating motives responsive to the melanoma microenvironment. J Invest Dermatol (2013) 0.87
MicroRNA silencing improves the tumor specificity of adenoviral transgene expression. Cancer Gene Ther (2012) 0.81
Retargeting adenoviral vectors to improve gene transfer into tumors. Cancer Gene Ther (2010) 0.81
Targeting different types of human meningioma and glioma cells using a novel adenoviral vector expressing GFP-TRAIL fusion protein from hTERT promoter. Cancer Cell Int (2011) 0.81
A novel hybrid promoter responsive to pathophysiological and pharmacological regulation. J Mol Med (Berl) (2011) 0.80
Peptide targeting of adenoviral vectors to augment tumor gene transfer. Cancer Gene Ther (2012) 0.78
Firefly luciferase gene: structure and expression in mammalian cells. Mol Cell Biol (1987) 26.70
SR alpha promoter: an efficient and versatile mammalian cDNA expression system composed of the simian virus 40 early promoter and the R-U5 segment of human T-cell leukemia virus type 1 long terminal repeat. Mol Cell Biol (1988) 12.84
Analysis of transcriptional regulatory signals of the HSV thymidine kinase gene: identification of an upstream control region. Cell (1981) 12.73
A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Mol Cell Biol (1992) 11.03
Endothelial PAS domain protein 1 (EPAS1), a transcription factor selectively expressed in endothelial cells. Genes Dev (1997) 8.51
Protein kinase B/Akt-mediated phosphorylation promotes nuclear exclusion of the winged helix transcription factor FKHR1. Proc Natl Acad Sci U S A (1999) 7.70
Integrative genomic approaches identify IKBKE as a breast cancer oncogene. Cell (2007) 7.60
NF-kappaB and the immune response. Oncogene (2006) 5.62
Hypoxia-inducible factor-1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growth. Proc Natl Acad Sci U S A (1997) 5.42
Adenovirus serotype 5 hexon mediates liver gene transfer. Cell (2008) 5.00
Adenovirus-mediated transfer of low density lipoprotein receptor gene acutely accelerates cholesterol clearance in normal mice. Proc Natl Acad Sci U S A (1993) 3.92
Multiple organ pathology, metabolic abnormalities and impaired homeostasis of reactive oxygen species in Epas1-/- mice. Nat Genet (2003) 3.78
Regulation of hypoxia-inducible factor 2alpha signaling by the stress-responsive deacetylase sirtuin 1. Science (2009) 3.64
Adenovirus serotype 5 hexon is critical for virus infection of hepatocytes in vivo. Proc Natl Acad Sci U S A (2008) 3.00
Tumour vascular targeting. Nat Rev Cancer (2005) 2.56
NF-kappaB and cancer: mechanisms and targets. Mol Carcinog (2006) 2.40
Molecular basis of the inflammatory response to adenovirus vectors. Gene Ther (2003) 2.29
VEGF prevents apoptosis of human microvascular endothelial cells via opposing effects on MAPK/ERK and SAPK/JNK signaling. Exp Cell Res (1999) 1.91
Association between expression of transcription factor Sp1 and increased vascular endothelial growth factor expression, advanced stage, and poor survival in patients with resected gastric cancer. Clin Cancer Res (2004) 1.84
Imaging angiogenesis and the microenvironment. APMIS (2008) 1.77
Efficient generation of recombinant adenoviral vectors by Cre-lox recombination in vitro. Mol Med (1999) 1.53
The size of endothelial fenestrae in human liver sinusoids: implications for hepatocyte-directed gene transfer. Gene Ther (2008) 1.41
Cancer-specific activation of the survivin promoter and its potential use in gene therapy. Cancer Gene Ther (2004) 1.32
Activation of the NF-kappaB pathway in human cytomegalovirus-infected cells is necessary for efficient transactivation of the major immediate-early promoter. J Virol (2004) 1.30
Plasminogen activator inhibitor 1: physiological and pathophysiological roles. News Physiol Sci (2002) 1.30
Antibody-based therapy for solid tumors. Cancer J (2008) 1.24
Human plasminogen activator inhibitor-1 gene. Promoter and structural gene nucleotide sequences. J Biol Chem (1988) 1.21
The role of the hypoxia-inducible factor in tumor metabolism growth and invasion. Bull Cancer (2006) 1.20
Cancer therapy with a replicating oncolytic adenovirus targeting the hypoxic microenvironment of tumors. Clin Cancer Res (2004) 1.19
HIF-2alpha-haploinsufficient mice have blunted retinal neovascularization due to impaired expression of a proangiogenic gene battery. Invest Ophthalmol Vis Sci (2008) 1.14
Hypoxia-mediated tumour targeting. Gene Ther (2003) 1.06
Angiogenic signalling pathways. Methods Mol Biol (2009) 1.03
Reduction of tumor cell migration and metastasis by adenoviral gene transfer of plasminogen activator inhibitors. Gene Ther (1999) 1.01
Gradients of transgene expression directed by the human myoglobin promoter in the developing mouse heart. Proc Natl Acad Sci U S A (1993) 1.00
The biologic basis of in vivo angiogenesis imaging. Front Biosci (2007) 0.98
Inflammation-induced recombinant protein expression in vivo using promoters from acute-phase protein genes. Proc Natl Acad Sci U S A (1995) 0.97
Increasing endothelial cell specific expression by the use of heterologous hypoxic and cytokine-inducible enhancers. Gene Ther (2000) 0.96
Transcription factors: their potential as targets for an individualized therapeutic approach to cancer. Cancer Gene Ther (2008) 0.91
Physiologically responsive gene therapy. Mol Med Today (1998) 0.83
Detection and quantitation of subgroup C adenovirus DNA in human tissue samples by real-time PCR. Methods Mol Med (2007) 0.81
Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery. J Clin Invest (1993) 9.56
Use of recombinant adenovirus for metabolic engineering of mammalian cells. Methods Cell Biol (1994) 4.65
Adenovirus-mediated transfer of low density lipoprotein receptor gene acutely accelerates cholesterol clearance in normal mice. Proc Natl Acad Sci U S A (1993) 3.92
NPAS2: an analog of clock operative in the mammalian forebrain. Science (2001) 3.88
Unconventional myosins in inner-ear sensory epithelia. J Cell Biol (1997) 3.64
T antigen and template requirements for SV40 DNA replication in vitro. EMBO J (1985) 3.59
New host cell system for regulated simian virus 40 DNA replication. Mol Cell Biol (1985) 2.82
Crystal structure of the receptor-binding domain of adenovirus type 5 fiber protein at 1.7 A resolution. Structure (1994) 2.80
Purification of the human immunodeficiency virus type 1 enhancer and TAR binding proteins EBP-1 and UBP-1. EMBO J (1988) 2.74
Characterization of the knob domain of the adenovirus type 5 fiber protein expressed in Escherichia coli. J Virol (1994) 2.56
Absence of host plasminogen activator inhibitor 1 prevents cancer invasion and vascularization. Nat Med (1998) 2.54
Nausea and vomiting of pregnancy: role of human chorionic gonadotropin and 17-hydroxyprogesterone. Obstet Gynecol (1980) 2.50
Structural basis of latency in plasminogen activator inhibitor-1. Nature (1992) 2.33
Adenovirus-mediated transfer of the muscle glycogen phosphorylase gene into hepatocytes confers altered regulation of glycogen metabolism. J Biol Chem (1992) 2.19
The first decade of aortocoronary bypass grafting, 1967-1977. A review. Circulation (1978) 2.01
The plasminogen activator inhibitor PAI-1 controls in vivo tumor vascularization by interaction with proteases, not vitronectin. Implications for antiangiogenic strategies. J Cell Biol (2001) 1.94
Inhibitory role of plasminogen activator inhibitor-1 in arterial wound healing and neointima formation: a gene targeting and gene transfer study in mice. Circulation (1997) 1.91
Terminally differentiated neonatal rat myocardial cells proliferate and maintain specific differentiated functions following expression of SV40 large T antigen. J Biol Chem (1988) 1.81
Serpin-resistant mutants of human tissue-type plasminogen activator. Nature (1989) 1.61
Human T-cell leukemia virus types I and II exhibit different DNase I protection patterns. J Virol (1988) 1.35
Effect of vitamin A on reversing the inhibitory effect of cortisone on healing of open wounds in animals and man. Ann Surg (1969) 1.34
Role of specific simian virus 40 sequences in the nuclease-sensitive structure in viral chromatin. Mol Cell Biol (1985) 1.28
Production of simian virus 40 large tumor antigen in bacteria: altered DNA-binding specificity and dna-replication activity of underphosphorylated large tumor antigen. Proc Natl Acad Sci U S A (1989) 1.20
Repeated B motifs in the human immunodeficiency virus type I long terminal repeat enhancer region do not exhibit cooperative factor binding. Proc Natl Acad Sci U S A (1988) 1.19
Deacylated lipopolysaccharide inhibits plasminogen activator inhibitor-1, prostacyclin, and prostaglandin E2 induction by lipopolysaccharide but not by tumor necrosis factor-alpha. J Immunol (1990) 1.16
Utilization of dental health services by Chicanos and Anglos. J Health Soc Behav (1978) 1.15
Enalapril does not enhance exercise capacity in patients after Fontan procedure. Circulation (1997) 1.15
Amino acid residues that affect interaction of tissue-type plasminogen activator with plasminogen activator inhibitor 1. Proc Natl Acad Sci U S A (1990) 1.13
Role of the NO/cGMP/K(ATP) pathway in the protective effects of sildenafil against ethanol-induced gastric damage in rats. Br J Pharmacol (2007) 1.12
Engineering of plasminogen activator inhibitor-1 to reduce the rate of latency transition. Nat Struct Biol (1995) 1.09
Local adenovirus-mediated transfer of human endothelial nitric oxide synthase reduces luminal narrowing after coronary angioplasty in pigs. Circulation (1998) 1.09
Variants of human tissue-type plasminogen activator that lack specific structural domains of the heavy chain. EMBO J (1988) 1.08
Deletion mutants which affect the nuclease-sensitive site in simian virus 40 chromatin. Mol Cell Biol (1982) 1.08
Adenoviral-mediated transfer of the human endothelial nitric oxide synthase gene reduces acute hypoxic pulmonary vasoconstriction in rats. J Clin Invest (1996) 1.07
Influence of intranasal cocaine on plasma constituents associated with endogenous thrombosis and thrombolysis. Am J Med (1994) 1.06
Uncoupling of chondroitin sulfate glycosaminoglycan synthesis by brefeldin A. J Cell Biol (1991) 1.04
The efficacy of cyanoacrylate-derived surgical adhesive for use in the repair of lacerations during competitive athletics. Am J Emerg Med (2000) 1.02
A randomized trial comparing radiation therapy versus concomitant radiation therapy and chemotherapy in carcinoma of the thoracic esophagus. Cancer (1991) 1.02
Adenovirus-mediated transfer of a gene encoding human apolipoprotein A-I into normal mice increases circulating high-density lipoprotein cholesterol. Circulation (1994) 1.02
Reduction of tumor cell migration and metastasis by adenoviral gene transfer of plasminogen activator inhibitors. Gene Ther (1999) 1.01
Genomic elements involved in transcriptional regulation of the rabbit surfactant protein-A gene. Mol Endocrinol (1993) 0.99
Inflammation-induced recombinant protein expression in vivo using promoters from acute-phase protein genes. Proc Natl Acad Sci U S A (1995) 0.97
Exocrine pancreatic tissue in human liver: a metaplastic process? Am J Surg Pathol (1990) 0.95
Characterization of a plasminogen activator produced by Acanthamoeba castellanii. Mol Biochem Parasitol (1995) 0.95
In vitro expression of a full-length DNA copy of cowpea mosaic virus B RNA: identification of the B RNA encoded 24-kd protein as a viral protease. EMBO J (1987) 0.95
Genetic modification of the vessel wall. Comparison of surgical and catheter-based techniques for delivery of recombinant adenovirus. Circulation (1994) 0.93
Structure of the receptor binding domain of adenovirus type 5 fiber protein. Curr Top Microbiol Immunol (1995) 0.93
Storage of tissue-type plasminogen activator in Weibel-Palade bodies of human endothelial cells. Arterioscler Thromb Vasc Biol (1999) 0.92
Mutational and immunochemical analysis of plasminogen activator inhibitor 1. J Biol Chem (1990) 0.91
A direct plating method for monitoring the contamination of Listeria monocytogenes in silage. Zentralbl Veterinarmed B (1992) 0.90
Effect of isometamidium on infections by Trypanosoma vivax and T. evansi in experimentally-infected animals. Vet Parasitol (1983) 0.89
Restoration of serine protease-inhibitor interaction by protein engineering. J Biol Chem (1990) 0.88
Oncocytic differentiation in intrahepatic biliary cystadenocarcinoma. Mod Pathol (1992) 0.88
Systemic hypertension induced by hepatic overexpression of human preproendothelin-1 in rats. J Clin Invest (1996) 0.87
Expression of human plasminogen activator inhibitor type-1 (PAI-1) in Escherichia coli as a soluble protein comprised of active and latent forms. Isolation and crystallization of latent PAI-1. Biochim Biophys Acta (1990) 0.87
Adenovirus-mediated transfer of a gene encoding acyloxyacyl hydrolase (AOAH) into mice increases tissue and plasma AOAH activity. Infect Immun (1996) 0.87
Bacillary angiomatosis in a child undergoing chemotherapy. J Pediatr (1992) 0.87
Properties of the active plum pox potyvirus RNA polymerase complex in defined glycerol gradient fractions. Virus Res (1995) 0.85
Use of lectin affinity chromatography for the purification of collagenase from human polymorphonuclear leukocytes. Biochemistry (1986) 0.85
Proteolytic activity of the cowpea mosaic virus encoded 24K protein synthesized in Escherichia coli. Virology (1987) 0.85
The adenovirus-mediated delivery of a reporter gene permits the assessment of androgen receptor function in genital skin fibroblast cultures. Stimulation of Gs and inhibition of G(o). J Biol Chem (1993) 0.85
Enhancement of adenovirus vector entry into CD70-positive B-cell Lines by using a bispecific CD70-adenovirus fiber antibody. J Virol (2001) 0.85
Urethral caruncle with atypical stromal cells simulating lymphoma or sarcoma--a distinctive pseudoneoplastic lesion of females. A report of six cases. Am J Surg Pathol (1996) 0.84
Prognostic factors associated with long-term survival in previously untreated metastatic renal cell carcinoma. Ann Oncol (2006) 0.83
Toxicity of an isolate of Bacillus thuringiensis subspecies darmstadiensis to adults of the Mexican fruit fly (diptera: (Diptera:Tephritidae) in the laboratory. J Econ Entomol (1997) 0.83
Analysis of nonpermissivity in mouse cells overexpressing simian virus 40 T antigen. J Virol (1987) 0.83
Cutaneous infection caused by Curvularia pallescens: a case report and review of the spectrum of disease. J Am Acad Dermatol (1995) 0.82
MicroRNA silencing improves the tumor specificity of adenoviral transgene expression. Cancer Gene Ther (2012) 0.81
Percutaneous adenoviral gene transfer into porcine coronary arteries: is catheter-based gene delivery adapted to coronary circulation? Hum Gene Ther (1999) 0.81
Atypical cutaneous changes after topical treatment with nitrogen mustard in patients with mycosis fungoides. Am J Dermatopathol (1996) 0.81
Multiple myosin isozymes and hair-cell function. Cold Spring Harb Symp Quant Biol (1996) 0.81
Retargeting adenoviral vectors to improve gene transfer into tumors. Cancer Gene Ther (2010) 0.81
Application of GFP-tagged Plum pox virus to study Prunus-PPV interactions at the whole plant and cellular levels. J Virol Methods (2005) 0.81
The Potyviridae cylindrical inclusion helicase: a key multipartner and multifunctional protein. Mol Plant Microbe Interact (2014) 0.81
Mechanisms for increasing stroke volume during static exercise with fixed heart rate in humans. J Appl Physiol (1985) (1997) 0.80
Relations between calcidiol serum levels and bone mineral density in postmenopausal women with low bone density. Calcif Tissue Int (1994) 0.80
Elevated levels of creatine kinase BB isoenzyme in three patients with adult osteopetrosis. N Engl J Med (1989) 0.79
Demyelination but no cognitive, motor or behavioral deficits after adenovirus-mediated gene transfer into the brain. Gene Ther (2000) 0.79
Elevated serum levels of creatine kinase BB in autosomal dominant osteopetrosis type II--a family study. Clin Genet (1992) 0.79
The end of the beginning. Gene transfer into the vessel wall. Circulation (1992) 0.79
Sequence requirements in the reactive-center loop of plasminogen-activator inhibitor-1 for recognition of plasminogen activators. Eur J Biochem (1996) 0.79
Lack of toxicity to adults of the Mexican fruit fly (Diptera: Tephritidae) of beta-exotoxin in Bacillus thuringiensis endotoxin preparations. J Econ Entomol (2000) 0.79
Injection of autologous blood for bleb leaks in New Zealand white rabbits. Invest Ophthalmol Vis Sci (1996) 0.79
A marker assisted selection protocol (MASP) to generate C57BL/6J or 129S6/SvEvTac speed congenic or consomic strains. Genesis (2001) 0.79
Molecular biology of tissue plasminogen activator and endogenous inhibitors. Mol Biol Med (1986) 0.79
DNA ploidy of basal cell carcinoma determined by image cytometry of fresh smears. J Cutan Pathol (1993) 0.78
Effect of passive water absorption on transepithelial movement of extracellular solutes in rat intestine. Kidney Int (1973) 0.78
Tissue-specific androgen responses in primary cultures of lacrimal epithelial cells studied by adenoviral gene transfer. J Steroid Biochem Mol Biol (2001) 0.78
Peptide targeting of adenoviral vectors to augment tumor gene transfer. Cancer Gene Ther (2012) 0.78
Relation of plasma lipoprotein(a) to infarct artery patency in survivors of myocardial infarction. Circulation (1993) 0.78
Statistical parameters in behavioral tasks and implications for sample size of C57BL/6J:129S6/SvEvTac mixed strain mice. Transgenic Res (2001) 0.78
Adenoviral mediated gene transfer to atherosclerotic arteries after balloon angioplasty. Am Heart J (1995) 0.77
Percutaneous gene therapy using recombinant adenoviruses encoding human herpes simplex virus thymidine kinase, human PAI-1, and human NOS3 in balloon-injured porcine coronary arteries. Hum Gene Ther (2000) 0.77
A case of agnathia, tetramelia and diaphragmatic hernia at 18 weeks' gestation. Ultrasound Obstet Gynecol (2004) 0.76
Adenovirus-mediated delivery into myocytes of muscle glycogen phosphorylase, the enzyme deficient in patients with glycogen-storage disease type V. Biochem J (1994) 0.76
Hispanics and cancer preventive behavior: the development of a behavioral model and its policy implications. J Health Soc Policy (1989) 0.76
Echocardiography in the diagnosis of Lutembacher syndrome. Cathet Cardiovasc Diagn (1978) 0.76
A novel attractant for Mexican fruit fly,Anastrepha ludens, from fermented host fruit. J Chem Ecol (1990) 0.75
Persistent neutrophilic meningitis due to Pseudallescheria boydii. Rev Infect Dis (1990) 0.75